Meibomian gland dysfunction (MGD) is a chronic condition where the oil-producing glands in your eyelids become blocked or produce poor-quality oil, leading to faster tear evaporation and dry, irritated eyes. It affects roughly 42% of adults across all ages, making it one of the most common eye conditions most people have never heard of.
Your eyelids contain dozens of tiny glands (called meibomian glands) that release a thin layer of oil every time you blink. This oil sits on top of your tear film and acts as a seal, slowing evaporation and keeping your eyes moist between blinks. When these glands malfunction, the protective oil layer breaks down, and your tears evaporate too quickly.
How the Glands Stop Working Properly
MGD follows a self-reinforcing cycle. It starts when the oil inside the glands thickens and stops flowing normally. Stagnant oil creates a breeding ground for bacteria that naturally live on the eyelid margin, including Staphylococcus species and Demodex mites. These organisms produce enzymes that break down the oil’s chemical structure, raising its melting point and making it even thicker and harder to secrete. The thicker the oil gets, the more the glands clog, which traps more oil, which feeds more bacteria.
The oil that does make it to the surface is chemically different from healthy oil. Normal meibum contains a specific balance of waxy and cholesterol-based fats, with nonpolar fats at the surface and polar fats sitting against the watery layer of tears. In severe MGD, this ratio shifts: cholesterol-based fats drop and inflammatory byproducts increase. The result is a tear film that breaks apart within seconds instead of holding stable between blinks.
Without a functional oil layer, tears evaporate rapidly. This concentrates the salt in the remaining tear fluid, triggering inflammation on the eye’s surface. That inflammation can then feed back into the glands themselves, worsening the blockage and creating a vicious circle between gland dysfunction and dry eye disease.
What MGD Feels Like
In its earliest stage, MGD produces no symptoms at all. The glands are already secreting thickened, cloudy oil, but the disruption isn’t severe enough to bother you. This is one reason the condition often goes undiagnosed until it progresses.
As it worsens through moderate stages, you may notice a gritty or burning sensation, itching, sensitivity to light, and eyes that feel tired or uncomfortable after reading or screen time. Your eyelid margins may look red or slightly swollen, and you might see small waxy plugs at the gland openings along the lash line. Blurred vision that clears with blinking is common, since the unstable tear film creates an uneven optical surface.
In advanced MGD, symptoms become more persistent and start limiting daily activities. The gland openings may be visibly clogged or displaced, and the eye’s surface can develop staining from chronic dryness, sometimes reaching the center of the cornea. At this point, some glands may have permanently dropped out, meaning they’ve atrophied and can no longer be recovered.
Who Gets It
MGD becomes more common with age. Among older adults, prevalence reaches nearly 48%. But younger people aren’t immune: about 36% of children and young adults show signs of gland dysfunction, often without realizing it. Contact lens wear, extended screen time (which reduces blink rate), certain medications like antihistamines and antidepressants, and skin conditions like rosacea all raise your risk. Hormonal changes, particularly the drop in androgens that occurs with aging, also play a role because these hormones help regulate oil production in the glands.
How It’s Diagnosed
An eye doctor diagnoses MGD by physically examining your eyelids and expressing (gently squeezing) the glands to evaluate the oil. Healthy glands produce clear, olive-oil-like fluid. In MGD, the secretions range from cloudy to granular to thick and opaque, sometimes described as having a toothpaste-like consistency. Each gland is scored on that spectrum, and the number of glands that can be expressed at all is also recorded.
Gland loss is measured using infrared imaging that shows the gland structures through the eyelid tissue. Loss is graded from zero (no loss) to three (more than two-thirds of the gland area gone). This matters because lost glands don’t regenerate, so early detection preserves function you can’t get back later. Your doctor may also measure how quickly your tear film breaks apart after a blink to assess how well the remaining oil layer is performing.
At-Home Care That Actually Helps
The foundation of MGD treatment is consistent eyelid hygiene. Warm compresses soften the thickened oil so it can flow out of the glands. Use a warm, wet washcloth placed gently over closed eyes for four to five minutes. The key is consistency: doing this once when your eyes feel bad won’t change the underlying problem. Daily application helps keep the oil flowing and prevents the stagnation that drives the cycle forward.
After warming, gentle massage of the eyelids from the base of the lashes toward the lid margin helps push softened oil out of the gland openings. Follow this with lid scrubs using a dilute cleanser to remove bacteria and debris from the lash line. Over time, this routine can reduce bacterial load, lower the melting point of the oil, and improve tear film stability.
Omega-3 fatty acid supplements are frequently recommended for MGD, but the evidence is genuinely mixed. One trial found that 1,000 mg of omega-3s daily (650 mg EPA plus 350 mg DHA) for three months reduced dry eye symptoms compared to placebo. Another trial using 2,240 mg daily for 12 weeks also showed symptom improvement. But a large, well-designed trial using 3,000 mg daily found no benefit over placebo. There is no consensus on the right dose or duration, so omega-3s may help some people but shouldn’t be treated as a reliable fix.
In-Office Treatments
When home care isn’t enough, two device-based treatments have the strongest evidence. Thermal pulsation (LipiFlow) applies controlled heat to the inner eyelid surface while simultaneously massaging the outer lid, clearing blocked glands more thoroughly than a washcloth can. Clinical trials show it improves tear film stability modestly (about 0.7 seconds longer before the tear film breaks up) and meaningfully reduces symptom scores.
Intense pulsed light (IPL) therapy, originally developed for skin conditions, targets the abnormal blood vessels and inflammation along the lid margin. It appears to be even more effective at improving tear film stability, adding roughly 2 seconds to tear break-up time. IPL also reduces the bacterial and Demodex burden on the eyelids, which addresses one of the root causes of the vicious cycle. Both treatments typically require multiple sessions, and their effects diminish over time, so many people return for periodic maintenance.
Why Early Treatment Matters
The most important thing to understand about MGD is that gland loss is irreversible. Once the gland tissue atrophies from prolonged blockage, no treatment can bring it back. In early and moderate stages, the glands are still structurally intact and can be unblocked. In advanced disease, when more than two-thirds of the gland area has dropped out, treatment options narrow to managing symptoms rather than restoring function. Starting a daily warm compress and lid hygiene routine at the first signs of discomfort, or even before symptoms appear if your doctor notices early gland changes during an exam, gives you the best chance of preserving these glands for the long term.